CC The Chemours Company Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
16:35
Jun 17
temple_eight
Buy CC on EPA deregulation and reshored fluoropolymer supply.
Buy CC on EPA deregulation and reshored fluoropolymer supply; dielectric fluids are structurally advantaged and likely regain market share upon re-approval.
CC The Chemours Company Long — —
16:35
Jun 16
temple_eight
Buy CC ahead of EPA PFAS deregulation decision (H2 2026).
Buy CC ahead of EPA PFAS deregulation decision (H2 2026); Chemours holds 30-35% Western market share in fluorochemicals and has a ready product line (Opteon 2P50) positioned to capture data center immersion-cooling demand unlocked by the rollback.
CC The Chemours Company Long 1ST — —
13:00
May 02
Nico Brugge Real Vision
Real Vision
AI chemical play possible double
Nico highlights Brad Smith's AI chemical play entered at $26.15. Brad sees a possible double over the next 10-12 months and plans to add more if it tumbles after earnings or DCA into the name.
CC The Chemours Company Long 1ST — —
Log in to see ideas

About CC Investor Commentary

Across the available history and selected sources, Buzzberg tracks CC (The Chemours Company) across 6 sources: 3 bullish vs 0 bearish calls from 6 authors. Historical directional balance: 38% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 8 total trade ideas tracked. Past 7 days, before deduplication: 1 other directions. Latest voices: temple_eight, Nico Brugge.